ChemoCentryx, Inc. Accounts Receivable
ChemoCentryx, Inc. had Accounts Receivable of $102.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2020-11-09
- 2020-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $102.00K.
- 2020-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $228.00K.
- 2020-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $168.00K.
- 2019-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $176.00K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2020-09-30 | $102.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $228.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $168.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $176.00K 10-Q · filed 2020-11-09 |
| 2018-12-31 | $2.06M 10-K · filed 2020-03-10 |
| 2018-09-30 | $336.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $164.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.70M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $51.09M 10-Q · filed 2018-11-08 |
| 2017-09-30 | $530.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $218.00K 10-Q · filed 2017-08-08 |
| 2016-12-31 | $30.20M 10-K · filed 2018-03-12 |
| 2016-09-30 | $120.00K 10-Q · filed 2016-11-08 |
| 2016-06-30 | $175.00K 10-Q · filed 2016-08-09 |